Skip to main content
. 2017 Aug 8;57(3):267–286. doi: 10.1007/s40262-017-0578-5

Table 1.

Pharmacokinetic parameters of micafungin in healthy subjects

Dose (mg) Subjects Mean pharmacokinetic parameters (% coefficient of variation) [range] References
Weight (kg) C max (mg/L) Cmax at SS (mg/L) C24h, mg/L C24h at SS (mg/L) AUC24 (mg h/L) AUC (mg h/L) t ½ (h) CL (mL/h/kg) V d (L/kg)
n SD or SS
100 26 SD 73.7 NR NR NR NR NR 136.4 (19)a 16.4 (16) 10.4 (20) 0.215 (13) [20]
8 SD 84 (11) 8.8 (20) [5.1–11.3] NR NR NR NR 125.9 (21) [84.3–160.4]a 14.6 (21) [11.7–20.4] 9.8 (18) [7.2–13.6] 0.199 (14) [0.167–0.260] [21]
9 SD 85 (18) 8.2 (17) [5.7–9.8] NR NR NR NR 120.9 (14) [102.6–149.4]a 15.1 (12) [12.4–17.8] 10 (16) [8–13.4] 0.202 (18) [0.168–0.284] [21]
27 SD 71.7 NR NR NR NR NR 133.4 (14)a 14.8 (9) 10.8 (11) NR [19]
8 SD 70.2 (22) 10.3 (24) NR 2b NR 96.8 (21) 142.4 (20)a 14.9 (10) 10.4 (20) 0.224 (25) [24]
Weighted average 75 9.1 (20) 133 (17) 15.4 (13) 10.4 (16) 0.2 (16)
150 23 SS NR NR 15.9 (13) NR 4b NR 180.9 (17) NR NR NR [22]
16 SS NR 12 (19) 16 (17) 2.5b 4b 116 (19) 182 (19) NR NR NR [23]
Weighted average 16 (15) 4 181 (18)

NR not reported, C max maximum plasma concentration, SD single dose, SS steady state, C 24h trough plasma concentration 24 h after dosing, AUC 24 area under the plasma concentration-time curve after a single dose from zero to 24 h, AUC area under the plasma concentration-time curve at steady state from zero to 24 h, or, when indicated, from zero to infinity after a single dose, t ½ terminal half-life, CL clearance, V d volume of distribution; average is weighted by the number of patients reported

a AUC after a single dose

b Values not reported but extracted from figures with time versus concentration curves